Glucokinase activator, circulating metabolites, and cardio-cerebrovascular diseases: a Mendelian randomization study
Abstract Background Glucokinase activator (GKA) has shown potential in influencing cardio-cerebrovascular diseases (CVDs), yet its metabolic mechanism remains unclear. Circulating metabolites play a significant role in the etiology of CVDs. We hypothesized that the effects of GKA on cardio-cerebrova...
Saved in:
| Main Authors: | Xiaohan Wang, Weimeng Cheng, Tingting Xu, Ping He, Tianyue Li, Ying Zhang, Zhonghai Wei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Cardiovascular Diabetology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12933-025-02851-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glucokinase Regulatory Protein as a Putative Target for Gestational Diabetes Mellitus and Related Complications: Evidence From the Mendelian Randomization Study
by: Weian Mao, et al.
Published: (2025-02-01) -
Sex Differences in Atrial Fibrillation: Evidence from Circulating Metabolites
by: Ningjing Qian, et al.
Published: (2025-03-01) -
Identification of circulating metabolites associated with chronic rhinosinusitis using Mendelian randomization analysis
by: Fan Jiang, et al.
Published: (2025-07-01) -
Glucokinase: evolution, regulatory properties, role in the pathogenesis of type 2 diabetes mellitus
by: L. A. Kuznetsova, et al.
Published: (2025-07-01) -
Mendelian randomization reveals probucol’s preventive role in Behçet’s disease via circulating metabolites
by: Zhang Hongchen, et al.
Published: (2025-03-01)